Biodesix
BDSX
45 hedge funds and large institutions have $98.5M invested in Biodesix in 2026 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 5 closing their positions.
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
74% more capital invested
Capital invested by funds: $56.6M → $98.5M (+$41.9M)
15% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 13
13% more funds holding
Funds holding: 40 → 45 (+5)
2.61% more ownership
Funds ownership: 39.58% → 42.19% (+2.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$2.51M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.63M |
| 3 |
PA
Perceptive Advisors
New York
|
+$1.61M |
| 4 |
Jane Street
New York
|
+$956K |
| 5 |
Walleye Capital
New York
|
+$943K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$1.19M |
| 2 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$1.03M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$860K |
| 4 |
Morgan Stanley
New York
|
-$479K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$377K |
BDSX Hedge Fund Activity: Q2 2026 in Review
45 of the 8,317 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q2 2026, worth a combined $98.5M — up 74% from $56.6M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new BDSX positions and 5 closed out — a net gain of 5 holders — while 15 added to existing stakes and 13 trimmed.
The largest buyer was Soleus Capital Management, adding an estimated $2.51M. The largest seller was AIGH Capital Management, cutting an estimated $1.19M.
- 45 institutional investors held Biodesix (BDSX) as of Q2 2026, up from 40 in Q1 2026.
- Funds reported $98.5M of Biodesix stock for Q2 2026, up 74% quarter-over-quarter.
- 10 funds opened new Biodesix positions in Q2 2026 and 5 closed out, a net change of +5 holders.
- The largest Biodesix buyer in Q2 2026 was Soleus Capital Management, an estimated $2.51M added.
- The largest Biodesix seller in Q2 2026 was AIGH Capital Management, an estimated $1.19M sold.
Based on aggregated 13F filings for Q2 2026.